Nachrichten zur Abbott Laboratories Aktie

Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript

ABT earnings call for the period ending June 30, 2024.…

Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript

…

Abbott raises annual profit forecast as strong medical device sales power quarterly beat

Abbott Laboratories raised its annual profit forecast on Thursday and beat Wall Street estimates for second-quarter earnings, buoyed by strong…

Abbott Laboratories: When Double-Digit Device Growth Apparently Isnt Enough

…

Heres How Abbott (ABT) is Placed Ahead of Q2 Earnings Release

Abbott Laboratories (ABT) second-quarter 2024 results are likely to reflect broad-based strength across several businesses and solid progress in the…

Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price

…

Global Precision Diagnostics Market Size To Worth USD 254.48 Billion By 2033 | CAGR Of 13%

The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…

Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033 | CAGR of 8.71%

The Global Cancer Diagnostics Market Size was Valued at USD 140.25 Billion in 2023 and the Worldwide Cancer Diagnostics Market…

Global Cardiac Prosthetic Devices Market Size To Exceed USD 14.4 Billion By 2033 | CAGR Of 8.11%

The Global Cardiac Prosthetic Devices Market Size was Valued at USD 6.6 Billion in 2023 and the Worldwide Cardiac Prosthetic…

Abbott Laboratories: Abpraller nach oben - Chartanalyse

Paris (www.aktiencheck.de) - Abbott Laboratories: Abpraller nach oben - Chartanalyse Die Abbott Laboratories-Aktie (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT)…

Global Tissue Diagnostics Market Size To Worth USD 10.8 Billion By 2033 | CAGR of 8.22%

The Global Tissue Diagnostics Market Size was Valued at USD 4.9 Billion in 2023 and the Worldwide Tissue Diagnostics Market…

Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%

The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…

The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine

Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine are included in this Analyst Blog.…

Abbott Laboratories: Umkehrformation - Chartanalyse

Paris (www.aktiencheck.de) - Abbott Laboratories: Umkehrformation - Chartanalyse Die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT)…

Top Analyst Reports for Abbott, BP & Gilead

Todays Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead…

Global Anal Fissure Treatment Market Size To Exceed USD 1986.1 Million By 2033 | CAGR Of 5.51%

The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…

Global Companion Diagnostics Market Size To Exceed USD 23.12 Billion By 2033 | CAGR Of 12.50%

The Global Companion Diagnostics Market Size was Valued at USD 7.12 Billion in 2023 and the Worldwide Companion Diagnostics Market…

Abbott Laboratories declares $0.55 dividend

…

Abbott Laboratories: Vor Hochlauf - Chartanalyse

Paris (www.aktiencheck.de) - Abbott Laboratories: Vor Hochlauf - Chartanalyse Die Abbott Laboratories-Aktie (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT) befindet…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Global Prostate Health Market Size To Worth USD 78.03 Billion By 2033 | CAGR Of 9.12%

The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…

Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers

Abbott Laboratories said the U.S. Food and Drug Administration has cleared for sale two new over-the-counter continuous glucose monitoring systems.…

Abbott Laboratories: Why I Agree With Wall Street On This One

…

NYSE Glitch Halts About a Dozen Stocks In Error

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open…

Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%

The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…

Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 46% gain

Abbott Laboratories ( NYSE:ABT ) shareholders might be concerned after seeing the share price drop 12% in the last...…

Global Minimally Invasive Surgical Instrument Market Size To Exceed USD 70.5 Billion By 2033 | CAGR of 8.74%

The Global Minimally Invasive Surgical Instrument Market Size was Valued at USD 30.5 Billion in 2023 and the Worldwide Minimally…

Top Stock Reports for UnitedHealth, Danaher & Abbott

Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and…

Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock

…

Drug Device Combination Products Market Worth Over $180 Billion by 2029 - Medtronic, Abbott Laboratories, and Boston Scientific Corporation Dominate the Industry

Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products Market - Global Industry Size, Share,…

Abbott Laboratories: Kursziel gekappt

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Barclays stufen die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol…

Analyst Report: Abbott Laboratories

…

Cardiac Marker Industry Trends, Opportunities, and Competitive Landscape 2018-2033: Features Profiles of Abbott Laboratories, Siemens, Danaher Corporation, bioMerieux, and Roche

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Marker Global Market Report 2024" report has been added…

Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry…

Stocks making the biggest moves midday: United Airlines, Travelers, Abbott Laboratories and more

These are the stocks posting the largest moves in midday trading.…

Abbott Laboratories narrows 2024 earnings guidance, shares slip By Investing.com

Abbott Laboratories narrows 2024 earnings guidance, shares slip…

Abbott beats quarterly profit estimates on strong medical device sales

Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as…

Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings

…

Global Theranostics Market Size To Worth USD 3.3 Billion By 2033 | CAGR of 5.68%

The Global Theranostics Market Size was Valued at USD 1.9 Billion in 2023 and the Worldwide Theranostics Market Size is…

Whats in Store for Abbott Laboratories (ABT) in Q1 Earnings?

Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.…

The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services

T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks…

Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks

Todays Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and…

Abbott Laboratories: Neue Produkte stehen im Mittelpunkt - Aktienanalyse

New York (www.aktiencheck.de) - Abbott Laboratories-Aktienanalyse von der Citigroup: Die Analysten der Citigroup stufen die Aktie von Abbott Laboratories (ISIN: US0028241000,…

Want Decades of Passive Income? 2 Stocks to Buy Now.

There arent many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may…

Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now

…

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has…

dpa-AFX ProFeed